Interpretable ADC-based radiomics models for differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
[OBJECTIVE] This study aimed to develop interpretable machine learning (ML) models using apparent diffusion coefficient (ADC) radiomics to differentiate hepatocellular carcinoma (HCC) from intrahepati
APA
Zhang Y, Yin X, et al. (2026). Interpretable ADC-based radiomics models for differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma.. Frontiers in oncology, 16, 1681920. https://doi.org/10.3389/fonc.2026.1681920
MLA
Zhang Y, et al.. "Interpretable ADC-based radiomics models for differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma.." Frontiers in oncology, vol. 16, 2026, pp. 1681920.
PMID
41710662
Abstract
[OBJECTIVE] This study aimed to develop interpretable machine learning (ML) models using apparent diffusion coefficient (ADC) radiomics to differentiate hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC).
[METHODS] Radiomic features were extracted from ADC maps of 83 pathologically confirmed HCC and 46 pathologically confirmed ICC patients who underwent MRI examinations. The least absolute shrinkage and selection operator (LASSO) method selected essential features for five ML models: logistic regression (LR), random forest (RF), gaussian naive bayes (GNB), support vector machine (SVM), and k-nearest neighbors (kNN). external validation was performed using 20 HCC and 20 ICC cases from the cancer imaging archive (TCIA) public database. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, accuracy, F1 score, calibration plots, and decision curve analysis (DCA). The best-performing model was interpreted using shapley additive explanations (SHAP).
[RESULTS] LASSO selected eight features. The models achieved training AUROCs of 0.84-0.95 and internal validation AUROCs of 0.78-0.91. The LR model demonstrated superior performance (training AUROC: 0.95; internal validation AUROC: 0.91; external validation AUROC: 0.85). Moreover, calibration plots and DCA confirmed that this model exhibited the best calibration and clinical utility. SHAP identified wavelet-LLL-firstorder-RootMeanSquared as the most impactful feature.
[CONCLUSIONS] The ADC-based LR model robustly differentiates HCC from ICC, with validated generalizability using public data, offering a promising non-invasive clinical tool.
[METHODS] Radiomic features were extracted from ADC maps of 83 pathologically confirmed HCC and 46 pathologically confirmed ICC patients who underwent MRI examinations. The least absolute shrinkage and selection operator (LASSO) method selected essential features for five ML models: logistic regression (LR), random forest (RF), gaussian naive bayes (GNB), support vector machine (SVM), and k-nearest neighbors (kNN). external validation was performed using 20 HCC and 20 ICC cases from the cancer imaging archive (TCIA) public database. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, accuracy, F1 score, calibration plots, and decision curve analysis (DCA). The best-performing model was interpreted using shapley additive explanations (SHAP).
[RESULTS] LASSO selected eight features. The models achieved training AUROCs of 0.84-0.95 and internal validation AUROCs of 0.78-0.91. The LR model demonstrated superior performance (training AUROC: 0.95; internal validation AUROC: 0.91; external validation AUROC: 0.85). Moreover, calibration plots and DCA confirmed that this model exhibited the best calibration and clinical utility. SHAP identified wavelet-LLL-firstorder-RootMeanSquared as the most impactful feature.
[CONCLUSIONS] The ADC-based LR model robustly differentiates HCC from ICC, with validated generalizability using public data, offering a promising non-invasive clinical tool.
같은 제1저자의 인용 많은 논문 (5)
- Comment on: "Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition".
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Impact of contrast-enhanced computed tomography surveillance frequency on survival outcomes in patients with stage I-III colorectal cancer: A propensity score-matched retrospective cohort study.
- Corrigendum to "TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer" [Int. Immunopharmacol. 168 (2026) 115798].
- Dietary restriction genes as modulators of breast cancer risk through metabolic pathways.